Cargando…
Longitudinal patterns of bone-targeted agent use among patients with solid tumors and bone metastases in the United States
PURPOSE: This study examined real-world long-term use of guideline-recommended bone targeted agents (BTA) among patients with metastatic solid tumors. METHODS: Adults with a solid tumor diagnosis followed by a bone metastasis diagnosis in 2012–2014 were identified from electronic medical records in...
Autores principales: | Qian, Yi, Bhowmik, Debajyoti, Kachru, Nandita, Hernandez, Rohini K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403861/ https://www.ncbi.nlm.nih.gov/pubmed/28120114 http://dx.doi.org/10.1007/s00520-017-3583-1 |
Ejemplares similares
-
Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States
por: Hernandez, Rohini K, et al.
Publicado: (2015) -
Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States
por: Arellano, Jorge, et al.
Publicado: (2015) -
Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States
por: Hernandez, Rohini K., et al.
Publicado: (2018) -
Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
por: von Moos, Roger, et al.
Publicado: (2017) -
Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States
por: Qian, Yi, et al.
Publicado: (2017)